Cart
sales@molnova.com
TTA-A8
CAS No. 1146395-46-1
TTA-A8( —— )
Catalog No. M36391 CAS No. 1146395-46-1
TTA-A8 is an antagonist of T-type calcium channel.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 645 | In Stock |
|
| 10MG | 785 | In Stock |
|
| 25MG | 1045 | In Stock |
|
| 50MG | 1283 | In Stock |
|
| 100MG | 1628 | In Stock |
|
| 200MG | 2195 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTTA-A8
-
NoteResearch use only, not for human use.
-
Brief DescriptionTTA-A8 is an antagonist of T-type calcium channel.
-
DescriptionTTA-A8 is an antagonist of T-type calcium channel.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1146395-46-1
-
Formula Weight430.42
-
Molecular FormulaC22H21F3N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@@H](NC(=O)Cc1ccc(cc1)-c1nccnc1C)c1ccc(OCC(F)(F)F)cn1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
O-1602
O-1602 is a novel GPR55 agonist, an atypical cannabinoid associated with the central nervous system and obesity, and is a candidate compound for the treatment of cystitis.
-
TTA-Q6
TTA-Q6, a selective T-type Ca2+ channel antagonist, exhibits potential antitumor and immunomodulatory activities for treating neurological disorders by inhibiting the uptake of extracellular calcium ions by tumor cells, thereby inducing intracellular calcium deficiency and endoplasmic reticulum (ER) stress.
-
JTV-519
JTV-519 (K201) is a Ca2+-dependent blocker of SERCA and a partial agonist of ryanodine receptors (RyRs).
